| Application | Comment | Organism |
|---|---|---|
| pharmacology | target for antifungal drug discovery | Cryptococcus neoformans |
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| GDP | - |
Cryptococcus neoformans | |
| mannose-1-phosphate | - |
Cryptococcus neoformans | |
| additional information | not inhibited by amphomycin or tunicamycin | Cryptococcus neoformans |
| Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|
| membrane | - |
Cryptococcus neoformans | 16020 | - |
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| additional information | Cryptococcus neoformans | role in the synthesis of the glucuronoxylomannan of the capsule | ? | - |
? |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Cryptococcus neoformans | - |
pathogenic fungus | - |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| additional information | role in the synthesis of the glucuronoxylomannan of the capsule | Cryptococcus neoformans | ? | - |
? |